MORE fusions & rearrangements precise diagnoses therapeutic targets answers for more patients .
Aventa tests use a novel DNA sequencing technology to detect actionable fusions and rearrangements in FFPE tumor samples that are missed by other clinical testing modalities
Actionable insights start here
Aventa FusionPlus
Find gene fusions targeted by approved and investigational therapies for solid tumors, such as NTRK, NRG1, ALK and HR genes like BRCA 1/2, as well as rearrangements critical for diagnosis and subtyping in tumors such as sarcomas and CNS tumors.
Aventa Lymphoma
Detect fusions and rearrangements crucial for diagnosis and management of B and T cell lymphomas, such as those that differentiate high and lower risk disease or eligibility for targeted therapies, with a whole-genome test that report across 417 genes – no need for stepwise FISH testing that can exhaust tissue or miss critical targets.
Ordering Aventa tests is easy
We handle specimen retrieval and return, and results are returned in about 10 business days.
We are committed to making our tests accessible and affordable
Aventa Assist offers programs to help patients whose costs for Aventa tests are not fully covered by insurance.